183 related articles for article (PubMed ID: 32103148)
1. 5-Azacytidine inhaled dry powder formulation profoundly improves pharmacokinetics and efficacy for lung cancer therapy through genome reprogramming.
Kuehl PJ; Tellez CS; Grimes MJ; March TH; Tessema M; Revelli DA; Mallis LM; Dye WW; Sniegowski T; Badenoch A; Burke M; Dubose D; Vodak DT; Picchi MA; Belinsky SA
Br J Cancer; 2020 Apr; 122(8):1194-1204. PubMed ID: 32103148
[TBL] [Abstract][Full Text] [Related]
2. Aerosolised 5-azacytidine suppresses tumour growth and reprogrammes the epigenome in an orthotopic lung cancer model.
Reed MD; Tellez CS; Grimes MJ; Picchi MA; Tessema M; Cheng YS; March TH; Kuehl PJ; Belinsky SA
Br J Cancer; 2013 Oct; 109(7):1775-81. PubMed ID: 24045660
[TBL] [Abstract][Full Text] [Related]
3. Inhalable dry powder prepared from folic acid-conjugated docetaxel liposomes alters pharmacodynamic and pharmacokinetic properties relevant to lung cancer chemotherapy.
Zhu X; Kong Y; Liu Q; Lu Y; Xing H; Lu X; Yang Y; Xu J; Li N; Zhao D; Chen X; Lu Y
Pulm Pharmacol Ther; 2019 Apr; 55():50-61. PubMed ID: 30738974
[TBL] [Abstract][Full Text] [Related]
4. Inhalation delivery dramatically improves the efficacy of topotecan for the treatment of local and distant lung cancer.
Kuehl PJ; Yingling CM; Dubose D; Burke M; Revelli DA; Chen W; Dye WW; Belinsky SA; Tessema M
Drug Deliv; 2021 Dec; 28(1):767-775. PubMed ID: 33860729
[TBL] [Abstract][Full Text] [Related]
5. Inhalation delivery of topotecan is superior to intravenous exposure for suppressing lung cancer in a preclinical model.
Kuehl PJ; Grimes MJ; Dubose D; Burke M; Revelli DA; Gigliotti AP; Belinsky SA; Tessema M
Drug Deliv; 2018 Nov; 25(1):1127-1136. PubMed ID: 29779406
[TBL] [Abstract][Full Text] [Related]
6. Present Situation and Future Progress of Inhaled Lung Cancer Therapy: Necessity of Inhaled Formulations with Drug Delivery Functions.
Okuda T; Okamoto H
Chem Pharm Bull (Tokyo); 2020; 68(7):589-602. PubMed ID: 32611996
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of rifampicin after repeated intra-tracheal administration of amorphous and crystalline powder formulations to Sprague Dawley rats.
Khadka P; Sinha S; Tucker IG; Dummer J; Hill PC; Katare R; Das SC
Eur J Pharm Biopharm; 2021 May; 162():1-11. PubMed ID: 33639255
[TBL] [Abstract][Full Text] [Related]
8. Highly respirable dry powder inhalable formulation of voriconazole with enhanced pulmonary bioavailability.
Arora S; Haghi M; Young PM; Kappl M; Traini D; Jain S
Expert Opin Drug Deliv; 2016; 13(2):183-93. PubMed ID: 26609733
[TBL] [Abstract][Full Text] [Related]
9. Development of inhalable hyaluronan/mannitol composite dry powders for flucytosine repositioning in local therapy of lung infections.
Costabile G; d'Angelo I; d'Emmanuele di Villa Bianca R; Mitidieri E; Pompili B; Del Porto P; Leoni L; Visca P; Miro A; Quaglia F; Imperi F; Sorrentino R; Ungaro F
J Control Release; 2016 Sep; 238():80-91. PubMed ID: 27449745
[TBL] [Abstract][Full Text] [Related]
10. SGI-110 and entinostat therapy reduces lung tumor burden and reprograms the epigenome.
Tellez CS; Grimes MJ; Picchi MA; Liu Y; March TH; Reed MD; Oganesian A; Taverna P; Belinsky SA
Int J Cancer; 2014 Nov; 135(9):2223-31. PubMed ID: 24668305
[TBL] [Abstract][Full Text] [Related]
11. Inhaled PYY(3-36) dry-powder formulation for appetite suppression.
Kuehl PJ; Boyden T; Dobry DE; Doyle-Eisele M; Friesen DT; McDonald JD; Murri BG; Vodak DT; Lyon DK
Drug Dev Ind Pharm; 2016 Jan; 42(1):150-156. PubMed ID: 26006332
[TBL] [Abstract][Full Text] [Related]
12. Inhaled Micro/Nanoparticulate Anticancer Drug Formulations: An Emerging Targeted Drug Delivery Strategy for Lung Cancers.
Islam N; Richard D
Curr Cancer Drug Targets; 2019; 19(3):162-178. PubMed ID: 29793407
[TBL] [Abstract][Full Text] [Related]
13. Characterization and pharmacokinetic analysis of crystalline versus amorphous rapamycin dry powder via pulmonary administration in rats.
Carvalho SR; Watts AB; Peters JI; Liu S; Hengsawas S; Escotet-Espinoza MS; Williams RO
Eur J Pharm Biopharm; 2014 Sep; 88(1):136-47. PubMed ID: 24859653
[TBL] [Abstract][Full Text] [Related]
14. Aerosol azacytidine inhibits orthotopic lung cancers in mice through Its DNA demethylation and gene reactivation effects.
Qiu X; Liang Y; Sellers RS; Perez-Soler R; Zou Y
PLoS One; 2014; 9(10):e109874. PubMed ID: 25347303
[TBL] [Abstract][Full Text] [Related]
15. Co-Spray-Dried Urea Cross-Linked Hyaluronic Acid and Sodium Ascorbyl Phosphate as Novel Inhalable Dry Powder Formulation.
Fallacara A; Busato L; Pozzoli M; Ghadiri M; Ong HX; Young PM; Manfredini S; Traini D
J Pharm Sci; 2019 Sep; 108(9):2964-2971. PubMed ID: 31009614
[TBL] [Abstract][Full Text] [Related]
16. Dissolution and Absorption of Inhaled Drug Particles in the Lungs.
Eedara BB; Bastola R; Das SC
Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559160
[TBL] [Abstract][Full Text] [Related]
17. Dry powder pharmaceutical biologics for inhalation therapy.
Chang RYK; Chow MYT; Khanal D; Chen D; Chan HK
Adv Drug Deliv Rev; 2021 May; 172():64-79. PubMed ID: 33705876
[TBL] [Abstract][Full Text] [Related]
18. Studies on the safety and the tissue distribution of inhaled high-dose amorphous and crystalline rifampicin in a rat model.
Khadka P; Sinha S; Tucker IG; Dummer J; Hill PC; Katare R; Das SC
Int J Pharm; 2021 Mar; 597():120345. PubMed ID: 33545287
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and pharmacodynamics of high doses of inhaled dry powder drugs.
Kukut Hatipoglu M; Hickey AJ; Garcia-Contreras L
Int J Pharm; 2018 Oct; 549(1-2):306-316. PubMed ID: 30077761
[TBL] [Abstract][Full Text] [Related]
20. Inhaled insulin is better absorbed when administered as a dry powder compared to solution in the presence or absence of alkylglycosides.
Hussain A; Majumder QH; Ahsan F
Pharm Res; 2006 Jan; 23(1):138-47. PubMed ID: 16320001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
